The cost-effective devices, which can be built in hours, leverage electrospray emitter technology to efficiently produce three-layered particles at scale.
The adjuvant can help the injectable polio vaccine induce a strong immune response in the GI tract, which is considered critical to eradicating the virus.
Startup Rock Zero is commercializing the research, which could cut costs and carbon emissions from lithium production. The company is part of MIT.nano's hard-tech accelerator, START.nano.